Rohit Agrawal

Mr. Rohit Agrawal

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2025 in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
Verified
Journal Article
Open access
RARohit Agrawal
Rohit Agrawal
RSRajeev Shrestha
Rajeev Shrestha
RPRamesh Sharma Poudel
Ramesh Sharma Poudel
SSShakti Shrestha
Shakti Shrestha
Inappropriate drug use is a significant global health issue, particularly in low-resource settings. This systematic review evaluates drug utilization across healthcare facilities in Nepal, a low-resource setting, using WHO core prescribing indicators to identify areas for improvement. A systematic review was conducted by searching literature in PubMed, Embase, CINAHL, INRUD bibliography, NepJOL, NepMed, and Google Scholar. Original studies assessing at least one WHO prescribing indicator in healthcare settings of Nepal were included. Eligible studies were analyzed descriptively and through proportional meta-analysis using a random-effects model. Eighty-eight studies were identified involving 2108 healthcare facilities and 60 191 patient encounters. The average of three drugs per encounter (95% CI: 2.5-3.2) was determined. Generic prescribing occurred only in 21.8% (95% CI: 15.6%-28.8%) prescriptions, showing a decline trend. Antibiotics were prescribed in 64.4% (95% CI: 57.7%-70.8%) encounters, with higher prevalence in secondary and tertiary care settings. Injectables were prescribed in 22.9% encounters (95% CI: 12.2-35.8). Drugs prescribed from WHO and Nepal essential medicine lists accounted for 53.0% (95% CI: 41.1-64.7) and 54.4% (95% CI: 47.7-60.9), respectively. The evaluation of drug utilization in Nepal suggested that the standards for WHO core prescribing indicators were not met, including overuse of antibiotics, underuse of essential medicines, and minimal generic prescribing. Targeted interventions, including prescriber education, policy reforms, enhanced monitoring, and regular prescription audits, are essential to promote rational prescribing and improve drug-related outcomes, including an opportunity to reduce antimicrobial resistance.

23 April 2026 in medRxiv
Verified
Preprint
Open access
PDF file
RGRoshan Giri
Roshan Giri
RARohit Agrawal
Rohit Agrawal
SLSabin Raj Lamichhane
Sabin Raj Lamichhane
SBSachita Barma
Sachita Barma
RMRachana Mahatara
Rachana Mahatara
Background: Nepal is experiencing a rapid demographic shift toward an aging population, with concurrent increase in morbidity and medication-related problems. Despite this, the multidimensional experience of medication-related burden (MRB) and refill adherence remain under-studied, particularly through the lens of socio-demographic, clinical and medication-related predictive features. This study aimed to assess MRB and medication adherence, and utilize machine learning (ML) architectures to identify complex factors influencing both. Methods: A cross-sectional study conducted among 390 ambulatory older patients (aged≥65 years) at Bharatpur Hospital, Nepal. MRB and medication adherence was assessed using Living with Medications Questionnaire (LMQ-3) and Adherence to Refills and Medication Scale (ARMS). Six ML architectures (Ordinary Least Square, LightGBM, Random Forest, XGBoost, SVM, and Penalized linear regression) were employed to predict ARMS and LMQ scores using various socio-demographic, clinical and medication-related predictive features. Model explainability was provided through SHAP (Shapley Additive exPlanations). All the analysis were performed using R. Results: The median LMQ-3 score was 110.0 (IQR 14.0), reflecting a moderate medication-related burden, while the median ARMS score of 21.0 (IQR 6.0) indicated moderate non-adherence. Random forest was the superior predictive model for both MRB and adherence. SHAP analysis revealed requiring assistance for medication and polypharmacy as the most significant drivers of both increased burden and poor adherence. Interaction analysis revealed that while polypharmacy typically worsens adherence, the risk is partially mitigated when patients receive physical or cognitive assistance. Additional, financial factors and employment status emerged as significant predictors. Conclusion: Older patients in Nepal face a significant medication-related burden and non-adherence, driven largely by regimen complexity and the need for support. The high predictive accuracy of ML models suggests that clinical interventions should prioritize simplified regimens and patient-centered counseling for those with high dependency. These findings provide a data-driven rational for policy-level medication optimization strategies in Nepal’s evolving healthcare system. Author Summary: As ageing occurs, there is high chance of presence of the chronic conditions. For management of these conditions, older people are often prescribed with multiple medications and often are vulnerable to those medications whose risk outweighs benefits. As a result there is high chance of occurrence of adverse effects; these effects have caused substantial degradation of the health related quality of life. Although pharmacotherapy is the mainstay of the chronic disease management, older people often feel medication burden. Medication burden is practical experience arising from the practical and psychological challenge while managing medications. Research shows high burden causes the non-adherence, a significant problem among older adults, causing significant problem in pharmacotherapy. Hence, we used validated Questionnaire for assessing the medication burden and medication adherence among older ambulatory adults attending the central hospital of Nepal. We used machine learning approach for the high prediction of the predictors influencing the medication related burden and mediation adherence. Moderate burden was observed among older adults and moderate non-adherence was also observed. We found needing assistance for medication management and multiple medications were the strongest predictors for both Medication burden and non-adherence. Our Study provides new insights and area for the implementation of clinical intervention for the medication optimization.